These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11716878)
1. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease. Burke RE Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878 [No Abstract] [Full Text] [Related]
2. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease]. Corti O; Brice A J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640 [TBL] [Abstract][Full Text] [Related]
3. Genetics of Parkinson's disease. Polymeropoulos MH Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165 [TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein and Parkinson's disease. Golbe LI Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675 [No Abstract] [Full Text] [Related]
5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
6. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Solano SM; Miller DW; Augood SJ; Young AB; Penney JB Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491 [TBL] [Abstract][Full Text] [Related]
7. [Parkinson's disease: what have we learned from the genes responsible for familial forms?]. Corti O; Brice A Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396 [TBL] [Abstract][Full Text] [Related]
8. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease. Baptista MJ; Cookson MR; Miller DW Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449 [TBL] [Abstract][Full Text] [Related]
14. Genetics of Parkinson's disease and biochemical studies of implicated gene products. Lansbury PT; Brice A Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362 [TBL] [Abstract][Full Text] [Related]
15. [Genetics and environmental factors of Parkinson disease]. Broussolle E; Thobois S Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660 [TBL] [Abstract][Full Text] [Related]
16. Genetics of Parkinson's disease and biochemical studies of implicated gene products. Lansbury PT; Brice A Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673 [TBL] [Abstract][Full Text] [Related]
17. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Goldberg MS; Lansbury PT Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819 [TBL] [Abstract][Full Text] [Related]
18. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618 [TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease: alpha-synuclein and parkin in protein aggregation and the reversal of unfolded protein stress. Jakobsen LD; Jensen PH Methods Mol Biol; 2003; 232():57-66. PubMed ID: 12840539 [No Abstract] [Full Text] [Related]
20. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease. Haywood AF; Staveley BE BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]